Robotic Surgery Platform Facilitates Laparoscopic Procedures
|
By HospiMedica International staff writers Posted on 09 Nov 2017 |

Image: A novel multi-port robotic system provides haptic feedback and eye-control (Photo courtesy of TransEnterix).
A new robotically assisted surgical device (RASD) helps direct small surgical instruments and a camera with precise movements and comfort.
The TransEnterix (Research Triangle Park, NC, USA) Senhance is a multi-port robotic system intended to assist in the accurate control of laparoscopic instruments for visualization and endoscopic manipulation of tissue, which includes grasping, cutting, approximation, ligation, blunt and sharp dissection, electrocautery, suturing, mobilization, and retraction. The system is designed so that the surgeons is provided with a three dimensional (3-D) high-definition view of the surgical field and remote control of three separate robotic arms while sitting at a cockpit console unit.
The system also includes technological characteristics that include force feedback, which provides the surgeon with haptic control to sense the stiffness of tissue being grasped by the robotic arm; and eye sensing camera control, which helps further control movement of the surgical tools. The system utilizes an open architecture, which allows hospitals and surgeons to leverage existing technology investments within the operating room ecosystem. The reusable instruments are based on laparoscopic colorectal and gynecological surgery tools.
“Millions of surgical procedures in the United States are performed each year laparoscopically with basic manual tools that limit surgeons’ capability, comfort, and control,” said Todd Pope, President and CEO of TransEnterix. “New choices are needed that enhance the senses, control and comfort of the surgeon, minimize the invasiveness of surgery for the patient, and maximize value for the hospital. Senhance is this new choice.”
“Surgeons are approaching the boundaries of minimally invasive care performed with handheld manual instruments and cameras, and are seeking new technologies that will allow us to advance beyond these boundaries,” said Steve Eubanks, MD, of Florida Hospital (Orlando, USA). “The future will be driven by the appropriate use of robotics and information tools in the operating room. The Senhance platform grants laparoscopic surgeons robotic precision, control of our vision, and haptic feedback, while minimizing procedural costs, and is a welcome revolution in our field.”
TransEnterix is a late-stage surgical robotics company, founded in 2006, that acquired the surgical robotics division of SOFAR S.p.A in 2015. This included the TELELAP ALF-X advanced robotic system, which is now being commercialized as the Senhance robotic system.
Related Links:
TransEnterix
The TransEnterix (Research Triangle Park, NC, USA) Senhance is a multi-port robotic system intended to assist in the accurate control of laparoscopic instruments for visualization and endoscopic manipulation of tissue, which includes grasping, cutting, approximation, ligation, blunt and sharp dissection, electrocautery, suturing, mobilization, and retraction. The system is designed so that the surgeons is provided with a three dimensional (3-D) high-definition view of the surgical field and remote control of three separate robotic arms while sitting at a cockpit console unit.
The system also includes technological characteristics that include force feedback, which provides the surgeon with haptic control to sense the stiffness of tissue being grasped by the robotic arm; and eye sensing camera control, which helps further control movement of the surgical tools. The system utilizes an open architecture, which allows hospitals and surgeons to leverage existing technology investments within the operating room ecosystem. The reusable instruments are based on laparoscopic colorectal and gynecological surgery tools.
“Millions of surgical procedures in the United States are performed each year laparoscopically with basic manual tools that limit surgeons’ capability, comfort, and control,” said Todd Pope, President and CEO of TransEnterix. “New choices are needed that enhance the senses, control and comfort of the surgeon, minimize the invasiveness of surgery for the patient, and maximize value for the hospital. Senhance is this new choice.”
“Surgeons are approaching the boundaries of minimally invasive care performed with handheld manual instruments and cameras, and are seeking new technologies that will allow us to advance beyond these boundaries,” said Steve Eubanks, MD, of Florida Hospital (Orlando, USA). “The future will be driven by the appropriate use of robotics and information tools in the operating room. The Senhance platform grants laparoscopic surgeons robotic precision, control of our vision, and haptic feedback, while minimizing procedural costs, and is a welcome revolution in our field.”
TransEnterix is a late-stage surgical robotics company, founded in 2006, that acquired the surgical robotics division of SOFAR S.p.A in 2015. This included the TELELAP ALF-X advanced robotic system, which is now being commercialized as the Senhance robotic system.
Related Links:
TransEnterix
Latest Surgical Techniques News
- Ultrasound Technology Aims to Replace Invasive BPH Procedures
- Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
- New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
- Robot-Assisted Brain Angiography Improves Procedural Outcomes
- Brain Mapping Technology Enhances Precision in Brain Tumor Resection
- Handheld Robotic System Expands Options for Total Knee Surgery
- VR Experience Reduces Patient Anxiety Before Kidney Stone Procedure
- Injectable Mini Livers Offer Hope for Patients Awaiting Transplant
- Pulsed Field Ablation Technology Cleared in Europe for Persistent AFib
- AI-Powered Imaging Brings Real-Time Margin Clarity to Breast Cancer Surgery
- Minimally Invasive Device Safely Treats Challenging Brain Aneurysms
- Surgical Robot Makes Complex Liver Tumor Surgery Safer and Less Invasive
- Neurostimulation Implant Reduces Seizure Burden in Drug-Resistant Epilepsy
- Minimally Invasive Procedure Effectively Treats Small Kidney Cancers
- Fluorescence Probe Paired with Engineered Enzymes Lights Up Tumors for Easier Surgical Removal
- Novel Hydrogel Could Become Bone Implant of the Future
Channels
Artificial Intelligence
view channelAI Analysis of Pericardial Fat Refines Long-Term Heart Disease Risk
Accurately identifying long-term cardiovascular disease risk in asymptomatic adults remains challenging for clinicians. Missed or underestimated risk delays preventive therapy and increases the chance... Read more
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read moreCritical Care
view channel
Noninvasive Monitoring Device Enables Earlier Intervention in Heart Failure
Hospitalizations for heart failure with preserved ejection fraction (HFpEF) remain common because lung congestion often worsens before symptoms prompt treatment changes. Missed early decompensation... Read more
Automated IV Labeling Solution Improves Infusion Safety and Efficiency
Medication administration in high-acuity settings is often complicated by multiple concurrent infusions, making accurate line identification essential. In a 10-hospital intensive care unit study, 60% of... Read morePatient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel







